{"title":"《阿布替尼治疗中重度特应性皮炎的有效性和安全性：随机临床试验的系统评价和荟萃分析》的更正。","authors":"","doi":"10.1155/drp/9753406","DOIUrl":null,"url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1155/2021/8382761.].</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":"2025 ","pages":"9753406"},"PeriodicalIF":1.9000,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457061/pdf/","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to \\\"Effectiveness and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials\\\".\",\"authors\":\"\",\"doi\":\"10.1155/drp/9753406\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>[This corrects the article DOI: 10.1155/2021/8382761.].</p>\",\"PeriodicalId\":11338,\"journal\":{\"name\":\"Dermatology Research and Practice\",\"volume\":\"2025 \",\"pages\":\"9753406\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-09-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457061/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dermatology Research and Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/drp/9753406\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatology Research and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/drp/9753406","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
Corrigendum to "Effectiveness and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials".
[This corrects the article DOI: 10.1155/2021/8382761.].
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
